Takeda Pharmaceutical Co. Ltd.'s Fiscal Year is From April To March - All Figures are in JPY, Trillions.
The item "Long-Term-Debt" stands at 4.35 Trillion Japanese Yens as of 09/30/2025.
As of the end of Takeda Pharmaceutical Co. Ltd.'s second quarter, the item "Long Term Debt" stands at 4.35 Trillion JPY. This represents an increase of 5.24 percent compared to it's value at the end of it's first quarter .
Regarding the One-Year-Change of the series, the current value constitutes a decrease of -1.71 percent compared to the value the year prior.
The 1 year change in percent is -1.71.
The 3 year change in percent is 4.39.
The 5 year change in percent is -6.04.
The 10 year change in percent is 591.75.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Long Term Debt | 905,699,262,464.00 |
![]() | Johnson & Johnson - Long Term Debt | 486,508,953,600.00 |
![]() | AbbVie Inc - Long Term Debt | 399,570,305,024.00 |
![]() | Roche Holding AG - Long Term Debt | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Long Term Debt | 280,205,508,085.11 |